Results 1 to 10 of about 417,779 (264)
Adenocarcinoma of the lung [PDF]
Thorax, 1969 The clinical and histological features of 53 cases of adenocarcinoma of the lung are presented. In more than one-third of the patients the tumour was a solitary nodule, raising the possibility that it might be a metastatic focus. Although histological features may suggest an origin from such sources as the kidney, uterus, ovary or bowel, nearly all ...
J. R. Hinds, G. C. Hitchcock
openaire +4 more sources
USP4 promotes proliferation and metastasis in human lung adenocarcinoma [PDF]
Scientific ReportsResearch the expression of USP4 in lung adenocarcinoma and its correlation with clinicopathological features and prognosis analysis, to explore the invasion and metastasis mechanism of USP4 in lung adenocarcinoma, and to clarify the mechanism of USP4’s ...
Yamin Wei +10 more
doaj +2 more sources
Hsa_circ_0079929 in lung adenocarcinoma and its biological implications in lung adenocarcinoma progression. [PDF]
J Cardiothorac SurgThis report investigated the expression, prognostic and biological implications of hsa_circ_0079929 in lung adenocarcinoma, which was based on clinical and experimental data.Patients with lung adenocarcinoma were screened and their clinical data and tissues (including cancerous tissues and adjacent normal tissues) were collected.
Shen Y, Han R, Yu X, Mao J.
europepmc +4 more sources
Hepatoid Adenocarcinoma of the Lung [PDF]
Technology in Cancer Research & Treatment, 2021 Hepatoid adenocarcinoma of the lung (HAL) is an comparatively rare malignant tumor originating from the lung with shorter survival. HAL morphologically and pathologically exhibits hepatocellular carcinoma (HCC)-like characteristics, while its clinical features resemble pulmonary adenocarcinoma.
Meihui Li, Ying Fan, Hongyang Lu
openaire +3 more sources
Acta Biochimica et Biophysica Sinica, 2023 The clinical oncogenic functions and mechanisms of activating transcription factor 1 (ATF1) in the progression of lung adenocarcinoma have not been completely elucidated.
Mei Jinhong +8 more
doaj +1 more source
Expression of MAD2L1 in Lung Adenocarcinoma and Its Effect on Immune Microenvironment
Zhongliu Fangzhi Yanjiu, 2022 Objective To investigate the expression of MAD2L1 in lung adenocarcinoma and its effect on the prognosis and immune microenvironment of patients. Methods The difference of MAD2L1 expression in lung adenocarcinoma tissue and normal lung tissue was ...
LIU Yingbo +3 more
doaj +1 more source
Frontiers in Oncology, 2022 BackgroundThe main aim of the study was to determine the risk factors of lung adenocarcinoma and to analyze the variations in the incidence of lung adenocarcinoma according to time, sex, and smoking status in North China.MethodsPatients with lung cancer ...
Daojuan Li +5 more
doaj +1 more source
Immune Resistance in Lung Adenocarcinoma [PDF]
Cancers, 2021 Lung cancer is the leading cancer killer worldwide, imposing grievous challenges for patients and clinicians. The incidence of lung adenocarcinoma (LUAD), the main histologic subtype of lung cancer, is still increasing in current-, ex-, and even non-smokers, whereas its five-year survival rate is approximately 15% as the vast majority of patients ...
Magda Spella, Georgios T. Stathopoulos
openaire +3 more sources
High GNG4 expression is associated with poor prognosis in patients with lung adenocarcinoma
Thoracic Cancer, 2022 Background The purpose of this study was to explore the reason for guanine nucleotide binding‐protein gamma subunit‐4 (GNG4) overexpression and the relationship between GNG4 overexpression and the poor prognosis of lung adenocarcinoma (LUAD) patients ...
Bodong Zhou +7 more
doaj +1 more source
World Journal of Surgical Oncology, 2022 Background Lung adenocarcinoma is the leading cause of cancer death worldwide. Recently, ubiquitin C-terminal hydrolase L1 (UCHL1) has been demonstrated to be highly expressed in many tumors and plays the role of an oncogene.
Jianbo Yao +9 more
doaj +1 more source